Hyperprolactinemia increases hypoprolactinemia decreases hydroxylase messenger acid levels arcuate nuclei substantia nigra zona incerta effects hypoprolactinemia hyperprolactinemia tyrosine hydroxylase TH signal levels dopaminergic neurons rats TH signal levels relative TH quantity arcuate nuclei zona incerta substantia nigra situ hybridization immunocytochemistry catalytic activity TH stalk-median eminence SME vitro rate DOPA accumulation DOPA decarboxylase brocresine Chronic administration bromocriptine BROMO dopamine DA agonist days rat PRL rPRL levels vehicle-treated controls BROMO treatment TH mRNA signal levels arcuate nuclei intensity TH arcuate-median eminence area rate DOPA accumulation SME Concomitant administration ovine PRL oPRL effects BROMO TH TH mRNA signal levels intensity TH immunostaining rate DOPA accumulation Treatment oPRL days TH mRNA signal levels arcuate nuclei TH activity SME vehicle Chronic treatment haloperidol DA antagonist circulating levels endogenous rPRL TH activity SME similar oPRL treatment contrast mRNA levels arcuate nuclei haloperidol-treated rats similar levels vehicle-treated animals effect PRL TH species specific oPRL rPRL jugular vein osmotic minipump TH mRNA levels arcuate nuclei control levels oPRL rPRL administration TH mRNA levels DA perikarya zona incerta substantia nigra treatment DA agonist DA antagonist PRL results hypoprolactinemia hyperprolactinemia TH mRNA levels tuberoinfundibular dopaminergic neurons alterations TH mRNA content decrease TH activity hypoprolactinemia hyperprolactinemia 